206 related articles for article (PubMed ID: 10053117)
1. Ovarian endometrioid-like yolk sac tumor treated by surgery alone, with recurrence at 12 years.
Kommoss F; Schmidt M; Merz E; Knapstein PG; Young RH; Scully RE
Gynecol Oncol; 1999 Mar; 72(3):421-4. PubMed ID: 10053117
[TBL] [Abstract][Full Text] [Related]
2. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
[TBL] [Abstract][Full Text] [Related]
3. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
4. Primary yolk sac tumor of the omentum: a case report and review of the literature.
Kim SW; Park JH; Lim MC; Park JY; Yoo CW; Park SY
Arch Gynecol Obstet; 2009 Feb; 279(2):189-92. PubMed ID: 18648830
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of patients with yolk sac tumors of the ovary.
Nawa A; Obata N; Kikkawa F; Kawai M; Nagasaka T; Goto S; Nishimori K; Nakashima N
Am J Obstet Gynecol; 2001 May; 184(6):1182-8. PubMed ID: 11349186
[TBL] [Abstract][Full Text] [Related]
6. Primary endodermal sinus tumor of the omentum.
Park NH; Ryu SY; Park IA; Kang SB; Lee HP
Gynecol Oncol; 1999 Mar; 72(3):427-30. PubMed ID: 10053119
[TBL] [Abstract][Full Text] [Related]
7. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
8. Ovarian Sertoli-Leydig cell tumor with heterologous gastrointestinal epithelium as a source of alpha-fetoprotein: a case report.
Watanabe T; Yamada H; Morimura Y; Abe M; Motoyama T; Sato A
J Obstet Gynaecol Res; 2008 Jun; 34(3):418-21. PubMed ID: 18588618
[TBL] [Abstract][Full Text] [Related]
9. Hepatoid malignancy of unknown origin--a diagnostic conundrum: review of literature and case report of collision with adenocarcinoma.
Gopaldas R; Kunasani R; Plymyer MR; Bloch RS
Surg Oncol; 2005 Jul; 14(1):11-25. PubMed ID: 15777886
[TBL] [Abstract][Full Text] [Related]
10. [Treatment outcome of children and adolescents with germ cell tumor after combined therapy---a report of 44 cases].
Sun XF; Yang QY; Zhen ZJ; Xia Y; Huang ZH; Ling JY
Ai Zheng; 2006 Dec; 25(12):1529-32. PubMed ID: 17166380
[TBL] [Abstract][Full Text] [Related]
11. Therapy of advanced ovarian juvenile granulosa cell tumors.
Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
[TBL] [Abstract][Full Text] [Related]
12. Primary yolk sac tumor of the omentum: a case report and literature review.
Haibin Z; Yue J; Yaxian X
Eur J Gynaecol Oncol; 2010; 31(6):682-4. PubMed ID: 21319517
[TBL] [Abstract][Full Text] [Related]
13. Yolk sac tumor of the ovary associated with endometrioid carcinoma with metastasis to the vagina: a case report.
McBee WC; Brainard J; Sawady J; Rose PG
Gynecol Oncol; 2007 Apr; 105(1):244-7. PubMed ID: 17316775
[TBL] [Abstract][Full Text] [Related]
14. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
15. Yolk sac tumor of the vulva: a case report with long-term disease-free survival.
Khunamornpong S; Siriaunkgul S; Suprasert P; Chitapanarux I
Gynecol Oncol; 2005 Apr; 97(1):238-42. PubMed ID: 15790466
[TBL] [Abstract][Full Text] [Related]
16. Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases.
Low JJ; Perrin LC; Crandon AJ; Hacker NF
Cancer; 2000 Jul; 89(2):391-8. PubMed ID: 10918171
[TBL] [Abstract][Full Text] [Related]
17. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
Silva EG; Gershenson DM; Malpica A; Deavers M
Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome and prognostic factors for yolk sac tumor of the ovary.
Umezu T; Kajiyama H; Terauchi M; Shibata K; Ino K; Nawa A; Kikkawa F
Nagoya J Med Sci; 2008 Mar; 70(1-2):29-34. PubMed ID: 18807293
[TBL] [Abstract][Full Text] [Related]
19. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
[TBL] [Abstract][Full Text] [Related]
20. [Primary combined chemotherapy following removal of an endodermal sinus tumor or yolk-sac tumor of the ovary (author's transl)].
Frick R; Rummel H; Wurster K; Kaufmann M
Geburtshilfe Frauenheilkd; 1976 Nov; 36(11):946-50. PubMed ID: 62689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
